These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5125062)

  • 1. [Clinical results of the intravenous administration of amantadine in patients with parkinsonism].
    Caliri F; Di Rosa AE; Meduri M; Megna G; Musolino R; Scuderi D
    Minerva Med; 1971 Oct; 62(82):3994-6. PubMed ID: 5125062
    [No Abstract]   [Full Text] [Related]  

  • 2. L-dopa and amantadine in the therapy of parkinsonism.
    Weeth JB; Shealy CN; Mercier DA
    Wis Med J; 1969 Nov; 68(11):325-8. PubMed ID: 4901055
    [No Abstract]   [Full Text] [Related]  

  • 3. [Amantadine therapy in parkinsonism].
    Pakkenberg H
    Ugeskr Laeger; 1973 Jan; 135(3):135-6. PubMed ID: 4685048
    [No Abstract]   [Full Text] [Related]  

  • 4. [Principles for amantadine therapy in parkinsonism].
    Gilland O
    Lakartidningen; 1972 Nov; 69(46):5343-5. PubMed ID: 4650743
    [No Abstract]   [Full Text] [Related]  

  • 5. [Accomplishment of the treatment and evaluation of treatment alternatives in parkinsonism].
    Presthus J
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2119. PubMed ID: 4773985
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined treatment of parkinsonism with L-dopa and amantadine.
    Hunter KR; Stern GM; Laurence DR; Armitage P
    Lancet; 1970 Sep; 2(7672):566. PubMed ID: 4195220
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of Parkinson's syndrome with L-dopa associated with diphenhydramine hydrochloride and amantadine hydrochloride].
    Scotti G
    Sist Nerv; 1970; 22(2):144-52. PubMed ID: 5504553
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the treatment of Parkinson's disease with intravenous administration of amantadine (77 cases)].
    Fasano VA; Urciuoli R; Broggi G
    Minerva Med; 1971 Oct; 62(82):3968-70. PubMed ID: 5125055
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preliminary observations on the use of intravenous amantadine and of the association of oral amantadine with anticholinergic drugs and with levo-dopa in the treatment of Parkinson's disease].
    Fasano VA; Urciuoli R; Broggi G
    Minerva Med; 1970 Jul; 61(53):2895-903. PubMed ID: 5428170
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma growth hormone and insulin response to levodopa and amantadine.
    Kytömäki O; Nousiainen R; Pekkarinen A; Rinne UK; Viljanen M
    J Neural Transm; 1973; 34(2):145-51. PubMed ID: 4722572
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of parkinsonism by amantadine and levodopa.
    Mawdsley C; Williams IR; Pullar IA; Davidson DL; Kinloch NE
    Clin Pharmacol Ther; 1972; 13(4):575-83. PubMed ID: 4557584
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of Levo-Dopa in the treatment of Parkinsonism (188 cases)].
    Fasano VA; Urciuoli R; Broggi G; Lombard GF
    Minerva Neurochir; 1970; 14(2):245-9. PubMed ID: 5515308
    [No Abstract]   [Full Text] [Related]  

  • 13. [Conservative therapy in the Parkinson syndrome].
    Birkmayer W
    Wien Med Wochenschr; 1971 Nov; 121(46):827-9. PubMed ID: 5138823
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of Parkinson's disease with levodopa. Principles. Practical advice. Considerations].
    Sigwald J
    Nouv Presse Med; 1972 Mar; 1(10):679-82. PubMed ID: 5022921
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intravenous and oral treatment with amantadine sulfate in Parkinson disease].
    Brenner M; Haass A; Jacobi P; Schimrigk K
    Nervenarzt; 1988 Mar; 59(3):180-4. PubMed ID: 3374720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amantadine. Prolonged clinical trial in 50 parkinsonian patients].
    Castaigne P; Laplane D; Dordain G
    Nouv Presse Med; 1972 Feb; 1(8):533-6. PubMed ID: 5012351
    [No Abstract]   [Full Text] [Related]  

  • 17. Administration of amandine to patients on optimum L-dopa dosage.
    Fehling C
    Acta Neurol Scand Suppl; 1972; 51():119-20. PubMed ID: 4514335
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined treatment of Parkinson's disease with amantadine and L-dopa.
    Scotti G
    Lancet; 1970 Jun; 1(7661):1394-5. PubMed ID: 4194144
    [No Abstract]   [Full Text] [Related]  

  • 19. Amantadine versus L-2 dopa and amatadine plus L-dopa.
    Fieschi C; Nardini M; Casacchia M; Tedone ME; Reitano M; Robotti E
    Lancet; 1970 Jul; 2(7664):154-5. PubMed ID: 4194541
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical effects of L-dopa in Parkinson's disease].
    Fasano VA
    Sist Nerv; 1970; 22(2):119-23. PubMed ID: 5504550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.